Quick Answer: Current evidence suggests a possible association between semaglutide and pancreatitis rather than a confirmed causal relationship, with clinical trials showing relatively low incidence rates
Still, these findings are largely based on case series rather than randomized trials
Anti-obesity drug therapy can be offered as an adjunct to a reduced-calorie diet and increased physical activity for weight management in adult patients with an initial body mass index (BMI) of 30 kg/m 2 or 2730 kg/m 2 in the presence of at least one weight-related comorbidity, e.g., dysglycemia, hypertension, dyslipidemia, or obstructive sleep apnea
Whats more, GLP-1 drugs may reduce the cravings for sweets and other unhealthy foods and change ones food preferences altogether
How long should you stay on tesamorelin
How Do Louisiana Patients Start Compounded Semaglutide Treatment